Company intelligence / Profile preview

HeartDrug Research

Towson, Maryland, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

HeartDrug Research is a clinical research organization formed in 1997 that provides high-quality care for patients participating in clinical trials, with a focus on cardiac and cardiovascular research. The company coordinates clinical trials and research projects using state-of-the-art technologies.

Therapeutic areas: Cardiovascular
Modalities: Not specified (likely clinical trial services, not drug development)
Industry: Contract Research Organization

Partnerships

Not specified or publicly disclosed

Beyond the preview

Go deeper on HeartDrug Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartDrug Research.

Explore the full profile